Repurposed antidepressant could be a new treatment for recurrent prostate cancer
A new interdisciplinary USC study shows that an antidepressant in use for decades, repurposed to fight prostate cancer, could help patients whose disease has returned following surgery or radiation.
The drug — an MAO inhibitor called phenelzine — represents a potential … Read More »
Grace Singson, PharmD Class of 2022, who received the Defining the Future Research Grant from the College of Psychiatric and Neurologic Pharmacists (CPNP), was named a